Perry Renshaw

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, Perry Renshaw sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials none currently recruiting 6 completed later-stage tilt upper quartile by trial count

Perry Renshaw: 7 sponsored US clinical trials, none currently recruiting.

Perry Renshaw sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 6 completed. 5 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Major Depressive Disorder, with 1 trials.

Upper-quartile sponsor footprint

Perry Renshaw sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

7 total, page 1 of 1

COMPLETED Phase 4

5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females

NCT02356107
COMPLETED Phase 4

Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder

NCT02134808
COMPLETED Phase 4

A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users

NCT02192931
COMPLETED Phase 4

Creatine as a Treatment Option for Depression in Methamphetamine Using Females

NCT01514630
COMPLETED Early Phase 1

Dose-Ranging Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder

NCT01601210
TERMINATED NA

Open-Label Creatine Study for Female Meth Users

NCT02189915
COMPLETED Phase 3

Citicoline Treatment of Methamphetamine Dependence

NCT00950352

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 1
Phase 4 4

Therapeutic Areas

Major Depressive Disorder 1

How the Perry Renshaw archive is shaped

7 indexed studies, none listed as recruiting (0% open); 6 completed (86%).

Phase mix: 5 late (III/IV) vs 1 early (I/II) (later-stage heavy).

Top condition: Major Depressive Disorder (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Perry Renshaw: archived-pipeline peers nationwide

Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Perry Renshaw sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share Perry Renshaw3M4Life Research89bioAbbott Diagnostics Division10xBio22nd Century Group23andMe3-C Institute for Social Development
Perry Renshaw sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Perry Renshaw sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Perry Renshaw page

7 registered trials is a research-attention snapshot, not an endorsement of Perry Renshaw or any single study.

  • None of Perry Renshaw's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Major Depressive Disorder is the condition Perry Renshaw studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Major Depressive Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Perry Renshaw pipeline card: 7 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.